Acta Scientific Women's Health (ASWH)(ISSN: 2582-3205)

Research Article Volume 3 Issue 8

Cardiovascular Manifestations of Hyperthyroidism

Rashmi Aggarwal1* and Pradeep Chugh2

1Department of Thyroid and Endocrine Research, Institute of Nuclear Medicine and Allied Sciences-INMAS, Delhi, India
2Department of Cardiology, Institute of Nuclear Medicine and Allied Sciences-INMAS, Delhi, India

*Corresponding Author: Rashmi Aggarwal, Department of Thyroid and Endocrine Research, Institute of Nuclear Medicine and Allied Sciences-INMAS, Delhi, India.

Received: July 20, 2021; Published: July 29, 2021

Abstract

Hyperthyroidism is associated with increased morbidity and mortality from cardiovascular disease [1]. Thyroid hormones significantly affect the cardiovascular systems. Both Heart and blood vessels are affected through genomic and non-genomic mechanisms. Tri iodothyronine (T3) the active thyroid hormone directly initiates the transcription of specific and non-specific genes acting on THR in the nucleus [2].

Non genomic effects of T3 are exerted on the plasma membrane, mitochondria and sarcoplasmic reticulum of cardiac myocytes.

Hyperthyroidism causes a spectrum of hemodynamic changes in the cardiovascular system like increase in heart rate, cardiac output, stroke volume, myocardial contractility and Left Ventricular mass [3]. Atrial fibrillation is a common cardiac manifestation of hyperthyroidism. Even subclinical hyperthyroidism has been also associated with an increased risk of atrial fibrillation [4].

In patients with pre - existing heart disease, the hyperdynamic circulation accompanying hyperthyroidism will further impair cardiac function leading on to congestive cardiac failure, worsening angina, atrial fibrillation and thromboembolism [5].

Keywords: Hyperthyroidism; Heart Rate; Atrial Fibrillation

References

  1. Franklyn JA., et al. “Mortality after the treatment of hyperthyroidism after radioactive iodine”. The New England Journal of Medicine 338 (1998): 712-718.
  2. Dillman WH. “Biochemical basis of thyroid hormone action in the heart”. The American Journal of Medicine 88 (1990): 626-630.
  3. Woeber KA. “Thyrotoxicosis and the heart”. The New England Journal of Medicine 327 (1992): 94-98.
  4. Marqusee E., et al. “Subclinical thyrotoxicosis”. Endocrinology and Metabolism Clinics of North America 27 (1998): 37-49.
  5. Ikram H. “The nature and prognosis of thyrotoxic heart disease”. QJ Medicine 54 (1985): 19-28.
  6. Klein I and Ojamaa K. “Thyroid hormones and the cardiovascular system”. The New England Journal of Medicine 334 (2001): 501-509.
  7. Fadel BM., et al. “Hyperthyroid heart disease”. Clinical Cardiology 23 (2000): 402-408.
  8. Polikar R., et al. “The thyroid and the heart”. Circulation 87 (1993): 1435-1441.
  9. Klein I and Ojamaa K. “Thyrotoxicosis and the heart”. Endocrinology and Metabolism Clinics of North America 27 (1998): 51-62.
  10. Brauman A., et al. “Mitral valve prolapse in hyperthyroidism of two different origins”. British Heart Journal 53 (1985): 374-377.
  11. Panagoulis C., et al. “Hyperthyroidism and the heart”. Hellenic Journal of Cardiology 49 (2008): 169-175.
  12. Agner T., et al. “A re-evaluation of atrial fibrillation in thyrotoxicosis”. Danish Medical Bulletin 31 (1948): 157-159.
  13. Vardas PE and Mavrakis HE. “Atrial fibrillation: a symptom treated as a disease?”. Hellenic Journal of Cardiology 47 (2006): 191-193.
  14. Sawin CT., et al. “Low serum thyrotropin concentration as a risk factor for atrial fibrillation in older persons”. The New England Journal of Medicine 331 (1994): 1249-1252.
  15. Saito I and Saruta T. “Hypertension in thyroid disorders”. Endocrinology and Metabolism Clinics of North America 23 (1994): 379-386.
  16. Thumheer R., et al. “Hyperthyroidism and pulmonary hypertension”. Journal of Internal Medicine 242 (1997): 185-188.
  17. Xenopoulos NP., et al. “Severe right heart failure in a patient with Graves` disease”. Clinical Cardiology 19 (1996): 903-905.
  18. Kenneth A and Woeber MD. “Thyrotoxicosis and the heart”. The New England Journal of Medicine 327 (1992): 94-98.

Citation

Citation: Rashmi Aggarwal and Pradeep Chugh. “Cardiovascular Manifestations of Hyperthyroidism". Acta Scientific Women's Health 3.8 (2021): 74-76.

Copyright

Copyright: © 2021 Rashmi Aggarwal and Pradeep Chugh. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days

Indexed In





News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2022.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US